Stacy Lindborg

CIK: 0001813667

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (4.8%)

Derivative conversions

Awards (A)20 (95.2%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

IMNN

Imunon, Inc.

DirectorOfficer

BCLI

BRAINSTORM CELL THERAPEUTICS INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (21 total)

IMNN
Imunon, Inc.
Oct 23, 2026
Award(A)
Direct
2.6K shares at avg. $1.24$3K
IMNN
Imunon, Inc.
Oct 9, 2026
Award(A)
Direct
3K shares at avg. $1.08$3K
IMNN
Imunon, Inc.
Sep 25, 2026
Award(A)
Direct
6.7K shares at avg. $1.41$9K
IMNN
Imunon, Inc.
Sep 11, 2026
Award(A)
Direct
5.5K shares at avg. $1.47$8K
IMNN
Imunon, Inc.
Aug 28, 2026
Award(A)
Direct
6.8K shares at avg. $1.60$11K
IMNN
Imunon, Inc.
Aug 14, 2026
Award(A)
Direct
6.6K shares at avg. $1.65$11K
IMNN
Imunon, Inc.
Jul 31, 2026
Award(A)
Direct
5K shares at avg. $1.59$8K
IMNN
Imunon, Inc.
Jul 17, 2026
Award(A)
Direct
4.9K shares at avg. $1.83$9K
IMNN
Imunon, Inc.
Jul 2, 2026
Award(A)
Direct
2.5K shares at avg. $1.91$5K
IMNN
Imunon, Inc.
Jun 25, 2026
Award(A)
Direct
67.2K shares at avg. $1.72$115K
IMNN
Imunon, Inc.
Jun 18, 2026
Award(A)
Direct
1.8K shares at avg. $1.82$3K
IMNN
Imunon, Inc.
Jun 5, 2026
Award(A)
Direct
1.6K shares at avg. $2.06$3K
IMNN
Imunon, Inc.
May 22, 2026
Award(A)
Direct
1.5K shares at avg. $2.20$3K
BCLI
BRAINSTORM CELL THERAPEUTICS INC.
Feb 26, 2026
Award(A)
Stock Option (Right to Buy)
Direct
150K shares at avg. $0.70-
IMNN
Imunon, Inc.
Jan 2, 2026
Award(A)
Stock Option (Right to Buy)
Direct
56.2K shares-
IMNN
Imunon, Inc.
Sep 6, 2025
Exercise(M)
Direct
1.7K shares-
IMNN
Imunon, Inc.
Aug 4, 2025
Award(A)
Stock Option (Right to Buy)
Direct
5K shares-
IMNN
Imunon, Inc.
Mar 14, 2025
Award(A)
Stock Option (Right to Buy)
Direct
75K shares-
BCLI
BRAINSTORM CELL THERAPEUTICS INC.
Jan 1, 2025
Award(A)
Direct
20K shares-
IMNN
Imunon, Inc.
Sep 6, 2024
Award(A)
Restricted Stock Units
Direct
25K shares-
IMNN
Imunon, Inc.
Sep 6, 2024
Award(A)
Stock Option (Right to Buy)
Direct
63.6K shares-

		Type	Shares	Price		Ownership
Oct 23, 2026	IMNN Imunon, Inc.	Award(A)	2,603	$1.24	$3,215	Direct
Oct 9, 2026	IMNN Imunon, Inc.	Award(A)	2,977	$1.08	$3,215	Direct
Sep 25, 2026	IMNN Imunon, Inc.	Award(A)	6,697	$1.41	$9,443	Direct
Sep 11, 2026	IMNN Imunon, Inc.	Award(A)	5,504	$1.47	$8,091	Direct
Aug 28, 2026	IMNN Imunon, Inc.	Award(A)	6,822	$1.60	$10,915	Direct
Aug 14, 2026	IMNN Imunon, Inc.	Award(A)	6,615	$1.65	$10,915	Direct
Jul 31, 2026	IMNN Imunon, Inc.	Award(A)	5,010	$1.59	$7,966	Direct
Jul 17, 2026	IMNN Imunon, Inc.	Award(A)	4,907	$1.83	$8,980	Direct
Jul 2, 2026	IMNN Imunon, Inc.	Award(A)	2,534	$1.91	$4,840	Direct
Jun 25, 2026	IMNN Imunon, Inc.	Award(A)	67,150	$1.72	$115,498	Direct
Jun 18, 2026	IMNN Imunon, Inc.	Award(A)	1,803	$1.82	$3,281	Direct
Jun 5, 2026	IMNN Imunon, Inc.	Award(A)	1,593	$2.06	$3,282	Direct
May 22, 2026	IMNN Imunon, Inc.	Award(A)	1,491	$2.20	$3,280	Direct
Feb 26, 2026	BCLI BRAINSTORM CELL THERAPEUTICS INC.	Award(A) Stock Option (Right to Buy)	150,000	$0.70	-	Direct
Jan 2, 2026	IMNN Imunon, Inc.	Award(A) Stock Option (Right to Buy)	56,187	-	-	Direct
Sep 6, 2025	IMNN Imunon, Inc.	Exercise(M)	1,667	-	-	Direct
Aug 4, 2025	IMNN Imunon, Inc.	Award(A) Stock Option (Right to Buy)	5,000	-	-	Direct
Mar 14, 2025	IMNN Imunon, Inc.	Award(A) Stock Option (Right to Buy)	75,000	-	-	Direct
Jan 1, 2025	BCLI BRAINSTORM CELL THERAPEUTICS INC.	Award(A)	20,000	-	$0	Direct
Sep 6, 2024	IMNN Imunon, Inc.	Award(A) Restricted Stock Units	25,000	-	-	Direct
Sep 6, 2024	IMNN Imunon, Inc.	Award(A) Stock Option (Right to Buy)	63,602	-	-	Direct

1-21 of 21 transactions

About Lindborg Stacy

Lindborg Stacy (SEC CIK 0001813667) files insider reports with the SEC as President and CEO of Imunon, Inc. (IMNN) and Director of BRAINSTORM CELL THERAPEUTICS INC. (BCLI).

Signal8 holds 21 ownership filings by Lindborg Stacy, all Form 4s, filed between Sep 10, 2024 and Oct 27, 2026. Those filings report 21 transactions, from Sep 6, 2024 to Oct 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lindborg Stacy's filings is in LAWRENCEVILLE, NJ.

Recent filings by Lindborg Stacy

Oct 23, 2026: Grant or award of IMNN shares (Form 4, code A).
Oct 9, 2026: Grant or award of IMNN shares (Form 4, code A).
Sep 25, 2026: Grant or award of IMNN shares (Form 4, code A).
Sep 11, 2026: Grant or award of IMNN shares (Form 4, code A).
Aug 28, 2026: Grant or award of IMNN shares (Form 4, code A).

Other insiders filing for Imunon, Inc. (IMNN)

Tardugno Michael H, Executive Chairman of Board
Faller Douglas Vincent, Chief Medical Officer
Eylward Susan, General Counsel and Corp Sec
Pellizzari Christine A, Director
Dentzer James E, Director
Fritz Frederick J., Director

How to read Form 4 transaction codes